Salkind Gene 4
4 · Mobiquity Technologies, Inc. · Filed Jan 2, 2026
Insider Transaction Report
Form 4
Salkind Gene
Director10% Owner
Transactions
- Award
Common Stock Options
2025-12-31+250,000→ 761,544 totalExercise: $1.10From: 2025-12-31Exp: 2030-12-31→ Common Stock (250,000 underlying)
Footnotes (2)
- [F1]Not applicable.
- [F2]Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share, (v) options to purchase 250,000 shares exercisable at $2.45 per share, and (vi) options to purchase 250,000 exercisable at $1.10 per share.